SKSung Hwan Kim

Sung Hwan Kim

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Sung Hwan Kim has a total of 147 co-authors. Here are the top co-authors by number of shared publications:

  • Joung Hun Byun

    Department of Thoracic and Cardiovascular Surgery, Gyeongsang National University College of Medicine, Changwon, Republic of Korea

    10 shared publications
  • Hyun Oh Park

    Department of Thoracic and Cardiovascular Surgery, Gyeongsang National University Hospital, Gyeongsang National University School of Medicine, Changwon

    8 shared publications
  • Jun Ho Yang

    From the Department of Thoracic and Cardiovascular Surgery, Gyeongsang National University College of Medicine and Gyeongsang National University Changwon Hospital, Changwon, South Korea

    8 shared publications
  • Seong Ho Moon

    From the Department of Thoracic and Cardiovascular Surgery, Gyeongsang National University College of Medicine and Gyeongsang National University Changwon Hospital, Changwon, South Korea

    7 shared publications
  • Hyun Oh Park

    Department of Thoracic and Cardiovascular Surgery, Gyeongsang National University Hospital, Gyeongsang National University College of Medicine, Jinju, Korea

    6 shared publications
  • Jong Woo Kim

    From the Department of Thoracic and Cardiovascular Surgery, Gyeongsang National University College of Medicine and Gyeongsang National University Changwon Hospital, Changwon, South Korea

    6 shared publications

Latest Publications

  • Open Access

    Conversion to Veno-arteriovenous Extracorporeal Membrane Oxygenation for Differential Hypoxia

    by Ho Jeong Cha, Jong Woo Kim, Dong Hoon Kang, Seong Ho Moon, Sung Hwan Kim, Jae Jun Jung, Jun Ho Yang, Joung Hun Byun

    Ho Jeong Cha, M.D., Jong Woo Kim, M.D., Dong Hoon Kang, M.D., Seong Ho Moon, M.D., Sung Hwan Kim, M.D., Jae Jun Jung, M.D., Jun Ho Yang, M.D., Joung Hun Byun, M.D.. J Chest Surg 2023;56:274-81. https://doi.org/10.5090/jcs.22.151


  • Open Access

    Fulminant Giant Cell Myocarditis following Heterologous Vaccination of ChAdOx1 nCoV-19 and Pfizer-BioNTech COVID-19

    by Dong-Hoon Kang, Joo-Young Na, Jun-Ho Yang, Seong-Ho Moon, Sung-Hwan Kim, Jae-Jun Jung, Ho-Jeong Cha, Jong-Hwa Ahn, Yong-Whi Park, Sang-Yeong Cho, et al.

    A 48-year-old female patient underwent a heart transplantation for acute fulminant myocarditis, following heterologous vaccination with the ChAdOx1 nCoV-19 and Pfizer-BioNTech COVID-19. She had no history of severe acute respiratory syndrome coronavirus-2 infection. She did not exhibit clinical signs or have laboratory findings of concomitant infection before or after vaccination. Heart transplantation was performed because her heart failed to recover with venoarterial extracorporeal oxygenation support. Organ autopsy revealed giant cell myocarditis, possibly related to the vaccines. Clinicians may have to consider the possibility of the development of giant cell myocarditis, especially in patients with rapidly deteriorating cardiac function and myocarditis symptoms after COVID-19 vaccination.


  • Left Ventricular Decompression by Transaortic Catheter Venting in Extracorporeal Membrane Oxygenation

    by Jae Jun Jung, Dong Hoon Kang, Seong Ho Moon, Jun Ho Yang, Sung Hwan Kim, Jong Woo Kim, Joung Hun Byun

    Venoarterial extracorporeal membrane oxygenation (VA-ECMO) has been widely applied to patients with cardiogenic shock. Left ventricle (LV) decompression is important when LV distension develops with pulmonary edema. The purpose of this study was to present the results of transaortic catheter venting (TACV) performed during VA-ECMO. We retrospectively reviewed the medical records of 18 patients who underwent both VA-ECMO and TACV between January 2017 and December 2019. Venoarterial extracorporeal membrane oxygenation was applied uneventfully. Lactate level and norepinephrine requirement for patients of weaning success were lower than those of patients of weaning failure after the application of TACV (p = 0.032 and p = 0.015, respectively). The successful weaning rate of ECMO was 77.8% (15/18) and survival rate was 50% (9/18). Transaortic catheter venting may be an easy, safe, and effective technique for LV decompression in patients with VA-ECMO for cardiogenic shock. Also, this technique may be helpful as an alternative or bridge method.


  • Open Access

    Veno-Arterial-Venous Extracorporeal Membrane Oxygenation in a Critically Ill Patient with Coronavirus Disease 2019

    by Joung Hun Byun, Dong Hoon Kang, Jong Woo Kim, Sung Hwan Kim, Seong Ho Moon, Jun Ho Yang, Jae Jun Jung, Oh-Hyun Cho, Sun In Hong, Byung-Han Ryu, et al.

    Patients with cardiopulmonary failure may not be fully supported with typical configurations of extracorporeal membrane oxygenation (ECMO), either veno-arterial (VA) or veno-venous (VV). Veno-arterial-venous (VAV)-ECMO is a technique used to support the cardiopulmonary systems during periods of inadequate gas exchange and perfusion. In the severe case of coronavirus disease 2019 (COVID-19), which simultaneously affects the heart and lung, VAV-ECMO may improve a patient’s recovery potential. We report the case of a 72-year-old woman with acute respiratory distress syndrome and circulatory failure following COVID-19, who was treated with VAV-ECMO.


  • Open Access

    Prognostic Role of S100A8 and S100A9 Protein Expressions in Non-small Cell Carcinoma of the Lung

    by Hyun Min Koh, Hyo Jung An, Gyung Hyuck Ko, Jeong Hee Lee, Jong Sil Lee, Dong Chul Kim, Jung Wook Yang, Min Hye Kim, Sung Hwan Kim, Kyung Nyeo Jeon, et al.

    S100A8 and S100A9 have been gaining recognition for modulating tumor growthand metastasis. This study aimed at evaluating the clinical significance of S100A8 and S100A9 innon-small cell lung cancer (NSCLC). We analyzed the relationship between S100A8and S100A9 expressions, clinicopathological characteristics, and prognostic significance in tumorcells and peritumoral inflammatory cells. The positive staining of S100A8 in tumorcells was significantly increased in male (p < .001), smoker (p = .034), surgical method other thanlobectomy (p = .024), squamous cell carcinoma (SQCC) (p < .001) and higher TNM stage (p = .022)compared with female, non-smoker, lobectomy, adenocarcinoma (ADC), and lower stage. Theproportion of tumor cells stained for S100A8 was related to histologic type (p < .001) and patientsex (p = .027). The proportion of inflammatory cells stained for S100A8 was correlated with patientage (p = .022), whereas the proportion of inflammatory cells stained for S100A9 was correlatedwith patient sex (p < .001) and smoking history (p = .031). Moreover, positive staining in tumorcells, more than 50% of the tumor cells stained and less than 30% of the inflammatory cellsstained for S100A8 and S100A9 suggested a tendency towards increased survivability in SQCCbut towards decreased survivability in ADC. S100A8 and S100A9 expressions might be potential prognostic markers in patients with NSCLC.


  • Open Access

    Quantitative severity of pulmonary emphysema as a prognostic factor for recurrence in patients with surgically resected non‐small cell lung cancer

    by Seung Jun Lee, Jung Wan Yoo, Sunmi Ju, Yu Ji Cho, Jong Duk Kim, Sung Hwan Kim, In‐Seok Jang, Bae Kwon Jeong, Gyeong‐Won Lee, Yi Yeong Jeong, et al.

    Background: Pulmonary emphysema is a major component of chronic obstructive pulmonary disease and lung cancer. However the prognostic significance of quantitative emphysema severity in patients with lung cancer is unclear. We analyzed whether numerical emphysema value is a prognostic factor for recurrence in patients with surgically resected non‐small cell lung cancer. Methods: We quantified emphysema severity of the whole lung and regional lobes in 45 patients (mean age 68.0 years) using an automated chest computed tomography‐based program. Predictive factors for recurrence were investigated using a Cox proportional hazards model. Recurrence‐free and overall survival was compared after dichotomization of patients according to whole lung emphysema severity. Results: The mean percentage emphysema ratio of the whole lung was 1.21 ± 2.04. Regional lobar emphysema severity was highest in the right middle lobe (1.93 ± 0.36), followed by right upper (1.35 ± 2.50), left upper (1.34 ± 2.12), left lower (1.05 ± 2.52), and right lower (0.78 ± 2.28) lobes. The low severity group showed significantly longer overall survival compared to the high severity group (log‐rank test, P = 0.018). Quantitative emphysema severity of the whole lung (hazard ratio 1.36; 95% confidence interval 1.0–1.73) and stage III (hazard ratio 6.17; 95% confidence interval 1.52–25.0) were independent predictors of recurrence after adjusting for age, gender, smoking status, and forced expiratory volume in one second. Conclusion: The severity of whole lung emphysema was independently associated with recurrence. Patients with non‐small cell lung cancer and marginal pulmonary emphysema at lower severity survive longer after curative‐intent surgery.


  • Open Access

    Comparison of stereotactic body radiotherapy versus metastasectomy outcomes in patients with pulmonary metastases

    by Yun Hee Lee, Ki Mun Kang, Hoon‐Sik Choi, In Bong Ha, Hojin Jeong, Jin Ho Song, In‐Seok Jang, Sung Hwan Kim, Jeong Won Lee, Dong Yoon Rhee, et al.

    Background: We compared the treatment outcomes of stereotactic body radiotherapy (SBRT) and metastasectomy in patients with pulmonary metastases.Methods: Twenty‐one patients received SBRT (total radiation doses 60 Gy in 3 fractions or 48 Gy in 4 fractions) and 30 underwent metastasectomy, most (93.3%) with wedge resection. The patients were followed for a median of 13.7 months. The tumor size in the SBRT group was larger than in the metastasectomy group (median 2.5 vs. 1.25 cm; P = 0.015). Patients with synchronous metastases were more likely to be treated with SBRT than with metastasectomy (P = 0.006).Results: There was no significant difference in the local control rates of the treatment groups (P = 0.163). Progression‐free survival (PFS) was longer in the metastasectomy than in the SBRT group (P = 0.02), with one and two‐year PFS rates of 51.1% and 46% versus 23.8% and 11.9%, respectively. The one and two‐year overall survival (OS) rates were 95% and 81.8% in the metastasectomy group and 79.5% and 68.2%, in the SBRT group, respectively. In multivariate analysis, synchronous metastasis was related to poor PFS, and tumor size was the most significant factor affecting OS. There were no significant differences in PFS and OS between treatment groups after dividing patients according to the presence or absence of synchronous metastases.Conclusions: SBRT is considered a suitable local modality against pulmonary metastases; however, patients with synchronous metastases are only likely to obtain a small benefit from local treatment with either SBRT or surgery.


  • Open Access

    A case report of pseudoaneurysm of left sinus of Valsalva invaded into the left ventricle with severe aortic regurgitation

    by Hyun Oh Park, Joung Hun Byun, Seong Ho Moon, Jong Woo Kim, Sung Hwan Kim, Ki Nyun Kim, Jae Jun Jung, Dong Hoon Kang, Jun Young Choi, Jun Ho Yang, et al.

    The pseudoaneurysms of sinus of Valsalva is an uncommon and serious complication of an infection, trauma, or after cardiac surgery or procedure. Pseudoaneurysms of sinus of Valsalva from left is rare. We describe a case of pseudoaneurysm of the left coronary sinus of Valsalva invaded into the left ventricle (LV) diagnosed by transthoracic echocardiography (TTE), transesophageal ecoccardiography (TEE), and multiple detector computed tomography (MDCT). A 44-year-old male patient had New York Heart Association (NYHA) class II / III dyspnea during 4 months. He underwent surgery including aortic valve replacement using mechanical prosthesis, and he was discharged well without significant complications on follow – up TTE and chest computed tomography (CT) post-operative 7 days. We report this rare case in which a ruptured pseudoaneurysm of sinus of Valsalva into LV with severe AR due to perforation of LCC was successfully-treated.


  • Open Access

    Case of a cardiac arrest patient who survived after extracorporeal cardiopulmonary resuscitation and 1.5 hours of resuscitation

    by Seong Ho Moon, Jong Woo Kim, Joung Hun Byun, Sung Hwan Kim, Ki Nyun Kim, Jun Young Choi, In Seok Jang, Chung Eun Lee, Jun Ho Yang, Dong Hun Kang, et al.

    Per the American Heart Association guidelines, extracorporeal cardiopulmonary resuscitation should be considered for in-hospital patients with easily reversible cardiac arrest. However, there are currently no consensus recommendations regarding resuscitation for prolonged cardiac arrest cases. We encountered a 48-year-old man who survived a cardiac arrest that lasted approximately 1.5 hours. He visited a local hospital's emergency department complaining of chest pain and dyspnea that had started 3 days earlier. Immediately after arriving in the emergency department, a cardiac arrest occurred; he was transferred to our hospital for extracorporeal membrane oxygenation (ECMO). Resuscitation was performed with strict adherence to the American Heart Association/American College of Cardiology advanced cardiac life support guidelines until ECMO could be placed. On hospital day 7, he had a full neurologic recovery. On hospital day 58, additional treatments, including orthotopic heart transplantation, were considered necessary; he was transferred to another hospital. To our knowledge, this is the first case in South Korea of patient survival with good neurologic outcomes after resuscitation that lasted as long as 1.5 hours. Documenting cases of prolonged resuscitation may lead to updated guidelines and improvement of outcomes of similar cases in future.


  • Open Access

    Risk Factors for Pneumonia in Ventilated Trauma Patients with Multiple Rib Fractures

    by Hyun Oh Park, Dong Hoon Kang, Seong Ho Moon, Jun Ho Yang, Sung Hwan Kim, Joung Hun Byun

    Hyun Oh Park, M.D., Dong Hoon Kang M.D., Seong Ho Moon, M.D., Jun Ho Yang, M.D., Sung Hwan Kim, M.D., Joung Hun Byun, M.D.. Korean J Thorac Cardiovasc Surg 2017;50:346-54. https://doi.org/10.5090/kjtcs.2017.50.5.346